Background: Madurella. mycetomatis is most common causative agent of mycetoma in Sudan and worldwide. No vaccines are available till now so design of effective vaccine is essential as protection tool. Peptide vaccine can overcome the common side effects of the conventional vaccines. The aim of this study was to design peptide based vaccine for M.Mycetomatis Translationally Controlled Tumor Protein (TCTP) using immunoinformatics tools.
Introduction
Mycetoma is a granulomatous subcutaneous chronic progressive infection. It is characterized by a painless swelling, development of draining sinuses that discharge different colors of pus and grains (1-3).Mycetoma is subdivided into actinomycetoma and eumycetoma (1, 4, 5) . . It is distributed worldwide, but it is endemic in tropical and subtropical regions (6) (7) (8) .These region sknown as the "Mycetoma belt" including (Sudan, Somalia, Yemen, Senegal, India, Mexico, Venezuela, Colombia and Argentina) while the most reported cases were from Sudan and Mexico, Sudan being the most endemic country (9) (10, 11) . Mycetoma can be found in areas geographically close proximity to Tropic of Cancer (1). It is categorized as one of the neglected tropical diseases at 2013 (6, 12) . Accurate data on its incidence and prevalence are not available (12) .The most common causative organism of mycetoma in Sudan and worldwide is Madurella mycetomatis (13) (14) (15) . Mycetoma is still widely distributed in Sudan with no effective treatment, no vaccines are available till now hence the design of an effective peptide vaccine is essential as protection tool against the disease (12). This study aimed to predict an insilico peptide based vaccine for mycetoma caused by M. mycetomatis using immunoinformatics.
The defense mechanisms against fungi usually range from early non-specific immune response to activation of specific adaptive immune responses by the production of cytokines of T helper-1 and T helper-2. Cell-mediated immunity can play a role in the pathogenesis of eumycetoma (16) .
The first well-characterized immunogenic antigen is Translationally Controlled Tumor Protein (TCTP).Significant IgG and IgM immune responses against this protein were determined. The level of antibodies is directly proportional to lesion size and duration of the disease (17). Different laboratory-based diagnostic techniques and tools were developed to determine and identify the causative agents of mycetoma (18) . Early detection and treatment are important to reduce morbidity and improve treatment outcomes (5, 16) . Antifungals are used for the treatment of eumycetoma, amputations and recurrences are common (4, 8) . Recently understanding of complex interactions between fungi and host led to exploration and design of novel vaccines (19) .The first genome sequence for this strain in Sudan was presented in 2016, better therapies for mycetoma will be developed using this sequence (13).TCTP is abundantly expressed in wide range of eukaryotic organisms located in the cytoplasm and the nucleus (20, 21). It is highly conserved protein and its expression is associated with malignancy and chemoresistance. TCTP plays important role in physiological events, such as immune responses ,cell proliferation and cell death (20) . TCTP is simultaneously the first identified monomolecular vaccine candidate for M.mycetomatis (17). Next to the TCTP, two antigenic proteins of M.mycetomatis were discovored, the glycolytic enzymes Fructose Biphosphate Aldolase ( FBA) and Pyruvate Kinase (PK), these antigens might also be useful as vaccine-candidates in the prevention of mycetoma (22) .The gene for this protein was found to be present in two variants in M. mycetomatis, with difference in 13% amino acids between the two encoded proteins (17) .This is the first computational vaccinology study conducted in mycetoma caused by M.mycetomatis using TCTP.
Materials and methods

Protein sequence retrieval
Nine Madurella mycetomatis TCTP sequences were retrieved from variants one and two from the National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/protein/?term=mycetoma+and+TCTP) database in August 2017.
Determination of conserved regions
Multiple sequence alignment (MSA) using ClustalW as in the BioEdit program, version 7.2.5 was used to obtain conserved regions among Madurella. mycetomatis TCTP (23).
B-cell epitope prediction
The reference Madurella. mycetomatis TCTP sequence was subjected to Bepipred linear epitope,
Emini surface accessibility and Kolaskar and Tongaonkar antigenicity methods in Immune
Epitope Data Base (IEDB) (22-24) (http://www.iedb.org/), that predict the probability of specific regions in the protein to bind to B cell receptor, being linear, in the surface and immunogenic, respectively.
Prediction of linear B-cell epitopes
Bepipred from immune epitope database (http://tools.iedb.org/bcell/) was used as linear B-cell epitopes prediction tool from the conserved region with a default threshold value of 0.240 (25) .
Prediction of surface accessibility
By using Emini surface accessibility prediction tool of the (IEDB) (22) (23) (24) (http://tools.iedb.org/bcell/result/).The surface accessible epitopes were predicted from the conserved region holding the default threshold value 1.000 (26) .
Prediction of epitopes antigenicity sites
The kolaskar and tongaonker antigenicity method (http://tools.iedb.org/bcell/result) was used to determine the antigenic sites with a default threshold value of 1.024 (27) .
MHC class I binding predictions
Analysis of peptide binding to MHC class I molecules was assessed by the (IEDB) MHC I prediction tool at (http://tools.iedb.org/mhci/result/). Peptide complex presentations to T lymphocytes undergo several steps. The attachment of cleaved peptides to MHC molecules step was predicted. Prediction methods was achieved by Artificial Neural Network (ANN) method (28) (29) (30) (31) (32) . Prior to prediction, all epitope lengths were set as 9amino acids, all conserved epitopes that bind to alleles at score less than 500 inhibitory concentration (IC50) were selected for further analysis (32).
MHC class II binding predictions
Analysis of peptide binding to MHC class II molecules was assessed by the IEDB MHC II prediction tool at (http://tools.iedb.org/mhcii/result/) (33, 34) . For MHC-II binding predication, human allele references set were used. , NN-align uses the artificial neural networks that allows for simultaneous identification of the MHC class II binding core epitopes and binding affinity from IEDB was used as prediction methods for MHC II (35). All conserved epitopes that bind to many alleles at score less than 100 half-maximal inhibitory concentration(IC50) were selected for further analysis (33) .
USCF Chimera version 1.8
It is a program for visualization and analysis of molecular structures and related data with highquality images and animations. It is produced by University of California, San Francisco.
Fallowing step by step to generate models for Madurella mycetomatis TCTP. (Available at https://www.cgl.ucsf.edu/chimera/).
Population coverage calculation
Selected MHC-I and MHC-II interacted alleles by the IEDB population coverage calculation tool at (http://tools.iedb.org/tools/population/iedb_input) (36) .
Results
Protein sequence retrieval
Retrieved TCTP sequences and their accession numbers are: ABB20812, ABB20815, ABB20814, ABB20813,ABB20811, ABB20810, ABB20809, ABB20808, ABB20807.
Alignment
Madurella mycetomatis TCTP conserved regions are shown in (figure 1).
Prediction of B-cell epitope:
In Bepipred Linear Epitope Prediction method; the average binders score of TCTP to B cell was 0.240, with maximum score 1.974 and a minimum score -1.296 (figure 2). Seven epitopes were predicted eliciting B lymphocyte from the conserved regions and all values equal or greater than the default threshold 0.24.
In Emini surface accessibility prediction; the average surface accessibility areas of the protein was scored as 1.000, with a maximum of 2.963 and a minimum of 0.073(figure 3). 37 epitopes were potentially in the surface by passing the default threshold 1.000 .
In Kolaskar and Tongaonkar antigenicity; the average of the antigenicity was 1.024, with a maximum of 1.188 and minimum of 0.892(figure 4). 15 epitopes gave score above the default threshold 1.024.
There are four epitopes successfully passed the three tools (DEVKEFETKAQAYV, EVKEFETKAQAYV, EFETKAQAYV, ETKAQAYV) as shown in (table 1) .
The positions of proposed conserved B cell epitopes in structural level of TCTP of Madurella.
mycetomatis are shown in ( figure 5 ).
Prediction of cytotoxic T-lymphocyte epitopes and interaction with MHC class I:
The reference TCTP sequence was analyzed using (IEDB) MHC-1 binding prediction tool to predict T cell epitope suggested interacting with different types of MHC Class I alleles, based on Artificial Neural Network (ANN) with half-maximal inhibitory concentration (IC50) <500
nm.111peptides were predicted to interact with different MHC-1alleles. The most promising epitopes and their corresponding MHC-1 alleles are shown in (Table 2) .Their positions at the structural level were determined by the aid of the chimera software as shown in (Figures   6,Figures7 ).
Prediction of The T cell epitopes and interaction with MHC class II
Reference TCTP variant was analyzed using (IEDB) MHC-II binding prediction tool based on NN-align with half-maximal inhibitory concentration (IC50) <100 nm; there were 274 predicted epitopes found to interact with MHC-II alleles.
The results of top four epitopes are listed in (Table 3) .Their positions at the structural level were determined by the aid of the chimera software as shown in (Figure 8,Figure 9 ).
Protein analysis
M.mycetomatis TCTP protein sequence was analyzed using both Bioedit program, version The whole world beside the mycetoma belt will benefit from this vaccine upon its successful development. TCTP is also present in many other species, so predicted peptides can be used as mulifactorial vaccine to protect from many diseases at the same time.
Many studies predicted peptide vaccines for different microorganisms such as, Rubella, Ebola, Dengue, Zika, Lagos rabies virus, HPV, HIV, HCV, malaria, anthrax, influenza, and swine fever using immunoinformatics tools (37) (38) (39) (40) (41) (42) (43) . A published study found that the peptide FFKEHGVPL had a very strong binding affinity to MHCII alleles which made it a strong candidate as epitope based vaccine against Fructose bisphosphate aldolase of Madurella mycetomatis (44) .
Limitations were seen upon the calcutation of the population coverages concerning the promising peptides with MHC class II for (Venezuela, Senegal, Mexico, India, Colombia and Argentina), beside the combined MHC class I and class II for (Senegal, Mexico, India, Colombia, Argentina and Venezuela)due to missed alleles in the database.The peptide YLKAYMKSV is shared between MHC class I and class II but its percentage in the population coverage was not so high.,
Further invivo and invitro studies are recommended to prove the effectiveness of these peptides for vaccination.
Conclusion:
We conclude that due to the fact that Peptide vaccines overcome the side effects of conventional vaccines, our study presented for the first time different peptide vaccines against TCTP of Madurella. Mycetomatis. The epitope (YMKSVKKAL) was the most promising one concerning its binding with MHCI alleles, while (FRLQSTSFD) was the most promising for MHC II. The epitope (YLKAYMKSV) is shared betweenMHC I and II. For the population coverage of M.
Mycetomatis TCTP vaccine Sudan (90.39%) had the highest percentage for MHC I.
